Advances in development of antimicrobial peptidomimetics as potential drugs

Natalia Molchanova, Paul Robert Hansen, Henrik Franzyk

104 Citations (Scopus)
124 Downloads (Pure)

Abstract

The rapid emergence of multidrug-resistant pathogens has evolved into a global health problem as current treatment options are failing for infections caused by pan-resistant bacteria. Hence, novel antibiotics are in high demand, and for this reason antimicrobial peptides (AMPs) have attracted considerable interest, since they often show broad-spectrum activity, fast killing and high cell selectivity. However, the therapeutic potential of natural AMPs is limited by their short plasma half-life. Antimicrobial peptidomimetics mimic the structure and biological activity of AMPs, but display extended stability in the presence of biological matrices. In the present review, focus is on the developments reported in the last decade with respect to their design, synthesis, antimicrobial activity, cytotoxic side effects as well as their potential applications as anti-infective agents. Specifically, only peptidomimetics with a modular structure of residues connected via amide linkages will be discussed. These comprise the classes of α-peptoids (N-alkylated glycine oligomers), β-peptoids (N-alkylated β-alanine oligomers), β3-peptides, α/β3-peptides, α-peptide/β-peptoid hybrids, α/γ N-acylated N-aminoethylpeptides (AApeptides), and oligoacyllysines (OAKs). Such peptidomimetics are of particular interest due to their potent antimicrobial activity, versatile design, and convenient optimization via assembly by standard solid-phase procedures.

Original languageEnglish
Article number1430
JournalMolecules
Volume22
Issue number9
Number of pages60
ISSN1420-3049
DOIs
Publication statusPublished - Sept 2017

Fingerprint

Dive into the research topics of 'Advances in development of antimicrobial peptidomimetics as potential drugs'. Together they form a unique fingerprint.

Cite this